Business
Study Publication
Study Publication.
About this update from Provexis Plc
[{"type":"text","content":"\n \nRNS Number : 8721R Provexis PLC 26 September 2017 \n\n27 September 2017\nProvexis plc\n \nStudy publication - consumption of Fruitflow® lowers blood pressure\n \nProvexis plc ('Provexis' or the 'Company'), the business that develops, licenses and sells the proprietary, scientifically-proven Fruitflow® heart-health functional food ingredient, is pleased to confirm the publication of an important pilot study for Fruitflow® in the International Journal of Food Sciences and Nutrition.\n \nThe study, titled 'Consumption of Fruitflow® lowers blood pressure in pre-hypertensive males: a randomised, placebo controlled, double blind, cross-over study' concerns the research undertaken by the Company and the University of Oslo into the relationship between Fruitflow® and blood pressure regulation, and it is expected to be a strong opportunity to promote Fruitflow® further across scientific, trade customer and consumer channels.\n \nThe study is available to view on the Company's website at: www.provexis.org/wp-content/uploads/2017/09/IJFSN-Fruitflow-blood-pressure-study-Sep-17.pdf\n \nThe study reflects the outcome of the research work undertaken by the Company and the University of Oslo, following a collaboration agreement between the parties which was signed in 2014.\n \nIn December 2016 the Company announced that the second stage of the collaboration work with the University of Oslo had been completed, which had seen the parties conduct a small clinical trial in Oslo by way of a proof of principle study. The study examined the acute effects of different amounts of Fruitflow® in powder format on parameters relating to blood pressure, such as systolic and diastolic blood pressure, mean arterial pressure, pulse pressure and heart rate. These blood pressure related parameters were monitored over a 24-hour period using ambulatory blood pressure monitoring. Platelet function was also measured. The trial subjects, who were healthy with no underlying cardiovascular disease or other conditions likely to affect blood pressure, received both placebo and Fruitflow® supplements in a blinded crossover design.\n \nResults from the pilot study indicated that a 150mg dose of Fruitflow® in powder format significantly lowered the average 24-hour systolic blood pressure compared to placebo. When the monitoring t...